Note 10 - Revenue and Geographic Information

3 Months Ended

Mar. 31, 2023

Notes to Financial Statements

Revenue from Contract with Customer [Text Block]

10. Revenue and Geographic Information

Revenue by product family is as follows:

	Three Months Ended March 31,
	2023		2022
OA Pain Management	$	22,633	$	20,964
Joint Preservation and Restoration		13,453		12,139
Non-Orthopedic		1,838		3,590
Total	$	37,924	$	36,693

Effective January 1, 2023, the Company beganto report revenue from product sales to veterinary customers within the Non-Orthopedic product family whereas such revenue had been previously reported within the OA Pain Management product family. Revenue from product sales to veterinary customers amounted to $0.5 million and $1.8 million for the three months ended March 31, 2023 and 2022, respectively, and are included within the Non-Orthopedic product family for all periods presented. Accordingly, revenue from product sales to veterinary customers in the prior period have been reclassified to conform to the current period presentation.

Revenue from the Company’s sole significant customer, DePuy Synthes Mitek Sports Medicine, part of the Johnson & Johnson Medical Companies, as a percentage of the Company’s total revenue was 43% and 39% for the three months ended March 31, 2023 and 2022, respectively.

Total revenue by geographic location based on the location of the customer in total and as a percentage of total revenue were as follows:

		Three Months Ended March 31,
	2023					2022
			Percentage of					Percentage of
	Revenue		Revenue			Revenue		Revenue
Geographic Location:
United States	$	27,288		72	%	$	26,773		73	%
Europe		5,662		15	%		5,796		16	%
Other		4,974		13	%		4,124		11	%
Total	$	37,924		100	%	$	36,693		100	%